Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Cash Flow Reinvestment Rate
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow Reinvestment Rate of 4.17x as of December 2024, reinvesting CN¥592.69 Million (capex CN¥233.87 Million plus investments CN¥-358.82 Million) from operating cash flow of CN¥142.23 Million. See 688799 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Hunan Warrant Pharmaceutical Co. Ltd. A operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Year-by-year capital reinvestment analysis for Hunan Warrant Pharmaceutical Co. Ltd. A. See financial agility of Hunan Warrant Pharmaceutical Co. Ltd. A to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.17x | CN¥592.69 Million | CN¥142.23 Million | CN¥233.87 Million | ▲ +516.8% |
| 2023 | 0.68x | CN¥144.89 Million | CN¥214.44 Million | CN¥105.76 Million | ▼ -71.0% |
| 2022 | 2.33x | CN¥362.47 Million | CN¥155.65 Million | CN¥131.85 Million | ▼ -56.2% |
| 2021 | 5.31x | CN¥609.40 Million | CN¥114.72 Million | CN¥92.10 Million | ▲ +383.9% |
| 2020 | 1.10x | CN¥114.89 Million | CN¥104.66 Million | CN¥53.75 Million | ▲ +158.5% |
| 2019 | 0.42x | CN¥49.55 Million | CN¥116.66 Million | CN¥24.34 Million | — |